Harvey Mamon Selected Research

Drug Therapy (Chemotherapy)

1/2022	Trastuzumab with trimodality treatment for oesophageal adenocarcinoma with HER2 overexpression (NRG Oncology/RTOG 1010): a multicentre, randomised, phase 3 trial.
1/2017	Persistence of dysphagia and odynophagia after mediastinal radiation and chemotherapy in patients with lung cancer or lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Harvey Mamon Research Topics

Disease

15	Neoplasms (Cancer) 01/2022 - 12/2005
4	Esophageal Neoplasms (Esophageal Cancer) 10/2021 - 08/2007
3	Rectal Neoplasms (Rectal Cancer) 01/2023 - 08/2007
3	Breast Neoplasms (Breast Cancer) 01/2017 - 02/2006
3	Communicable Diseases (Infectious Diseases) 11/2016 - 02/2013
2	Deglutition Disorders (Dysphagia) 01/2023 - 01/2017
2	Adenocarcinoma 01/2022 - 06/2014
2	Microsatellite Instability 01/2021 - 01/2018
1	Dyspnea (Shortness of Breath) 01/2023
1	Edema (Dropsy) 01/2023
1	Vomiting 01/2023
1	Fatigue 01/2023
1	Nausea 01/2023
1	Diarrhea 01/2023
1	Mucositis 01/2023
1	Constipation 01/2023
1	Lymphadenopathy 01/2022
1	Sudden Death 01/2022
1	Fistula 01/2022
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2022
1	Infections 01/2022
1	Sepsis (Septicemia) 01/2022
1	Anastomotic Leak 01/2022
1	Inflammation (Inflammations) 12/2021
1	Fibrosis (Cirrhosis) 12/2021
1	Foreign Bodies (Foreign Body) 12/2021
1	Esophageal Squamous Cell Carcinoma 12/2021
1	COVID-19 01/2021
1	Anus Neoplasms (Anal Cancer) 01/2019
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2019
1	Polyps 01/2018
1	Colorectal Neoplasms (Colorectal Cancer) 01/2018
1	Lung Neoplasms (Lung Cancer) 01/2017
1	Lymphoma (Lymphomas) 01/2017
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2017
1	Heartburn (Pyrosis) 01/2017
1	Lymphopenia (Lymphocytopenia) 06/2014
1	Sarcoma (Soft Tissue Sarcoma) 07/2012

Drug/Important Bio-Agent (IBA)

9	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 02/2006
7	Cell-Free Nucleic AcidsIBA 01/2018 - 02/2006
2	Biomarkers (Surrogate Marker)IBA 03/2011 - 02/2006
1	Fluorouracil (Carac)FDA LinkGeneric 01/2023
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2022
1	Carboplatin (JM8)FDA LinkGeneric 01/2022
1	Trastuzumab (Herceptin)FDA Link 01/2022
1	Keratins (Keratin)IBA 12/2021
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2019
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2019
1	PolymersIBA 01/2018
1	Proton Pump InhibitorsIBA 01/2017
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 06/2014
1	Alanine Transaminase (SGPT)IBA 06/2014
1	Proteins (Proteins, Gene)FDA Link 07/2012
1	Epidermal Growth Factor (EGF)IBA 05/2008
1	Glucose (Dextrose)FDA LinkGeneric 08/2007
1	ParaffinIBA 04/2006
1	Formaldehyde (Formol)FDA Link 04/2006
1	Nucleic AcidsIBA 02/2006
1	Tumor Biomarkers (Tumor Markers)IBA 02/2006

Therapy/Procedure

6	Radiotherapy 01/2022 - 12/2005
5	Neoadjuvant Therapy 01/2023 - 08/2007
4	Chemoradiotherapy 01/2022 - 01/2016
4	Therapeutics 12/2021 - 08/2007
2	Aftercare (After-Treatment) 01/2023 - 01/2017
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2017
1	Organ Transplantation 11/2016